Alessandro Brunelli, MD, St. James’s University Hospital, Leeds, UK, discusses a risk model to predict the delivery of adjuvant chemotherapy which was evaluated in a multi-center retrospective analysis. This study identified several factors associated with the probability of initiating adjuvant chemotherapy after lung resection in node-positive patients, which can be used to support decision-making on the timing of systemic treatment. This interview took place during the virtual European Lung Cancer Congress 2022.